Answers are grounded in this paper and cite their sources.
Engineered living hydrogels (ELHs) represent a convergence between biomaterial science and synthetic biology, wherein living and non-living components are combined to overcome the limitations of traditional hydrogels. While early ELHs relied on passive cell encapsulation, the next-generation of ELHs, cell-node hydrogels (CNGels), employ cells as active crosslinking nodes, fundamentally transforming hydrogel functionality and performance. This strategy enables dynamic bioactive properties, including self-healing, self-growing, self-degrading, and real-time programmable behavior through cellular sensing and adaptation. These CNGels have been successfully engineered using both mammalian and non-mammalian cells by employing a variety of strategies from metabolic glycoengineering and bioorthogonal click chemistry to SpyTag/SpyCatcher-mediated assembly, enabling a wide range of biomedical applications from tissue engineering and regenerative medicine to bioremediation. This review highlights the current fabrication strategies and mechanistic principles of CNGels, as well as provides a forward-looking perspective on optimizing CNGels for clinical and industrial deployment.
No takes yet. Share an insight, caveat, or question.
Fatima et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: